This move is the latest in a series of attempts by the Trump administration to eliminate DEI/DEIA programs and reduce NIH funding.

CAR T-cell therapy showed encouraging efficacy and good safety in newly diagnosed Ph-positive ALL,” the researchers wrote.

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

Progress has been made in reducing overall cancer mortality, largely driven by sustained declines in lung cancer,” the researchers wrote.

Until prospective data are available, researchers recommend that patients with ER-low breast cancer “should be counseled regarding the potential benefit” of adjuvant endocrine therapy.

The Trump administration is weighing a plan to cut nearly a third of the federal health budget, according to a memo obtained by CNN.

Pediatric cancer patients and their caregivers largely prefer to access test results immediately through the patient portal rather than wait to hear about results from oncologists, according to survey ...

Cancer apps can provide patients with helpful tools, but there are risks associated with these apps, according to experts.

A senior government health researcher has said he is retiring early because the NIH has censored his latest findings on ultra-processed food.

Researchers conducted the IMPROVE trial to evaluate whether a 3-week pause in BTK inhibitor use would improve immunity after COVID-19 booster vaccination without negatively affecting disease control ...

Layoffs across health agencies have eliminated workers who handled Freedom of Information Act requests at the CDC, FDA, and ...

(HealthDay News) — The US Food and Drug Administration (FDA) announced that it is shifting away from requiring animal testing for the development of monoclonal antibodies and other drugs and will ...